Scientifically Based Recommendations
for Nutritional Supplements.
The following are some recommendations as to some of the most
beneficial supplements that may be worth consuming to improve
health, prolong life, and increase performance, based on current
scientific research. However, while nutritional supplementation
may be helpful, there is no substitute for a healthy diet. There are also
recommendations for avoiding certain supplements due to safety or efficacy
concerns. This section is continually being worked on and revised.
Please note: You
should always check with your physician before consuming any
supplements, as some of them may be contraindicated for health
conditions you may have or may interact unfavorably with
medications you are taking.
Research has also shown that elderly with lower levels of vitamin E are more likely to have memory problems.(15) Vitamin E may help to prevent the oxidative (free radical) damage of brain cells that tends to occur over time and may play a role in preventing Alzheimer's disease.
References:
1. Pizzorno J. Total Wellness.
Rocklin, CA: Prima Publishing, 1998, p.62.
2. Burton GW, et al. Human plasma and tissue
alpha-tocopherol concentrations in response to
supplementation with deuterated natural and synthetic
vitamin E. Am J Clin Nutr. 1998; 67:669-684.
3. Murray MT. Encyclopedia of Nutritional Supplements.
CA: Prima Publishing, 1996, p.53.
4. Princen HMG, et al. Supplementation with low doses of
Vitamin E protects LDL from lipid peroxidation in men and
women. Arterioscler, Thromb, and Vasc Biol.
1995; 15: 325-333.
5. Devaraj S, Jialal I. Alpha-tocopherol decreases
interleukin-1 beta release from activated human monocytes
by inhibition of 5-lipoxygenase. Arterioscler,
Thromb, and Vasc Biol. 1999; 19(4):1125-33.
6. Belcher JD, Balla J, Balla G, et al. Vitamin E, LDL,
and endothelium. Brief oral vitamin supplementation
prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler
Thromb. 1993; 13: 1779-1789.
7. Leppälä JM, Virtamo J, Fogelholm R, et al. Vitamin E and
beta carotene supplementation in high risk for stroke: A subgroup
analysis of the alpha-tocopherol, beta carotene cancer prevention study.
Archives of Neurology. 2000; 57:1503-1509.
8. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E
consumption and the risk of coronary heart disease in
women. New Engl J of Med. 1993; 328:1444-1449.
9. Stephans NG, Parsons A, Schofield PM, et al. Randomized controlled trial of vitamin E in patients with
coronary disease: Cambridge Heart Antioxidant Study. Lancet.
1996; 347(9004): 1849-54.
10. Davey PJ, et al. Cost-effectiveness of vitamin E
therapy is the treatment of patients with
angiographically proven narrowing (CHAOS trial). Am J Cardiol. 1998; 82:414-7.
11. Meydani SN, Meydani M, Blumberg JB, et al. Vitamin E
supplementation and in vivo immune response in healthy
elderly subjects. A randomized controlled trial. JAMA.
1997; 277: 1380-6.
12. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E
consumption and the risk of coronary heart disease in
men. New Engl J of Med. 1993; 328: 1450-1456.
13. Tutuncu NB, Bayraktar M, Varli K. Reversal of
defective nerve conduction with vitamin E supplementation
in type 2 diabetes: a preliminary study. Diabetes
Care. 1998; 21(11):1915-1918.
14. Diabetes Care. 1999; 22:1245-1251.
15. Perkins AJ, Hendrie HC, Callahan CM, et al. Association of
antioxidants with memory in a multiethnic elderly sample using the Third
National Health and Nutrition Examination Survey. .American Journal of Epidemiology. 1999; 150:
37-44.
16. American Journal of Epidemiology. 1999;
150:290-300.
17. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E
supplementation on cardiovascular events and cancer: a randomized
controlled trial. JAMA.
2005; 293 (11): 1338-47.
18. Bostick RM, Potter JD, McKenzie DR, et al. Reduced risk of colon
cancer with high intakes of vitamin E: The Iowa Women's Health Study. Cancer
Res 1993;15: 4230-17.
19. Jacobs EJ, Henion AK, Briggs PJ, et al. Vitamin C and vitamin E
supplement use and bladder cancer mortality in a large cohort of US men
and women. American Journal of Epidemiology. 2002;156: 1002-10
Omega 3 Fatty Acids.
There are three main omega 3 fatty acids--alpha linoleic acid (ALA),
eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). Along
with the main omega 6 fatty acid, linoleic acid (LA), alpha linoleic acid
(ALA) is considered essential to human health. EPA and DHA can be
synthesized from ALA, but humans are not very efficient at this
conversion, so an argument can be made that EPA and DHA should also be
considered essential.
Omega 3 fatty acids are
extremely important in promoting health and in preventing disease and the
best source of the omega-3 oil is in the form of fish
oil. Flax seed, flax seed oil, soybeans, soybean oil, canola
oil, and walnuts are also good sources of
omega 3 fatty acids, particularly alpha linolenic acid (ALA). However,
while humans can
convert the 18 carbon ALA into the 20 carbon EPA or the 22 carbon DHA,
this is not a very efficient process. Studies show that approximately only 8% of dietary
ALA is converted to EPA and only 0-4% is converted to DHA in healthy
young men. It is much more efficient to consume a high quality fish oil
supplement and/or consume fish on a weekly basis, in addition to
consuming some ALA containing foods.
There are many positive health benefits of increasing consumption of
omega-3 fats. They are essential for normal growth and
development. All cell membranes are made of phospholipids,
which incorporate fatty acids, and a higher consumption of omega
3 fatty acids has been shown to positively influence membrane
formation.
Omega-3 fats have been shown to be helpful in preventing and treating
heart disease(5,6), diabetes(7), kidney disease(8), rheumatoid
arthritis(9), chronic obstructive pulmonary disease(10), and various
inflammatory disorders. This is done partially through regulation
of hormones in the body known as prostaglandins. For example,
higher consumption of omega-3 fats leads to decreased concentration of
thromboxane A2, which leads to platelet aggregation and
vasoconstriction. Therefore, consumption of omega-3 fats reduces
the likelihood of heart attacks and strokes. On the other hand, by
decreasing platelet aggregation, blood clotting is decreased, so be
careful if you are taking coumadin or warfarin to reduce blood clotting.
Fish oil has been shown to reduce hardening of the arteries.
Fish oil supplements appear to reduce the death rate in
former heart attack patients. A little oil on the valve train can help
keep a car running smoothly and extend its life span. The same holds
true, it seems, for humans. The 1999 GISSI-Prevenzione trial found that omega-3 oils appear
to reduce the chances that former heart attack patients will suffer a
fatal cardiovascular event, and may protect them from other causes
of death, as well.(12)
Researchers tracked the efficacy of nutritional
supplement programs for 11,324 patients who recently
suffered heart attacks from hundreds of hospitals and
clinics throughout Italy. They examined the effects of
daily supplementation with omega-3 fatty acids (1 g), vitamin E (300 mg), or both, on fatal and non-fatal
cardiovascular events over the next three and a half
years.
Compared to controls, the group receiving omega-3 fatty
acids showed a 30% decrease in cardiovascular-related
deaths, and a 20% reduction in mortality from all causes.
Overall, the rigorous statistical analysis revealed a
combined 20% drop in the overall rates for cardiovascular
death, non-fatal heart attack, and non-fatal stroke. While vitamin E supplementation did not significantly
affect the combined, overall outcomes in the patients,
researchers nevertheless pointed out "an indication
of a possible beneficial effect of vitamin E" in
several important secondary indices, including a 20%
reduction in all types of cardiovascular deaths.
A recent review paper looked at all the published research and compared
the benefits of fish oil compared with diet, lipid lowering drugs
categorized as statins, fibrates and resins, and niacin.(13) While the
fibrate class of drugs failed to influence overall mortality and mildly
elevated non-cardiac mortality, and while diet, resins, and niacin
appeared to provide insignificant benefits, statins and omega-3 fatty
acids significantly lowered both overall and coronary heart disease
mortality risk during the trial periods. The risk of overall mortality was
reduced by 13 percent by statins and 23 percent by omega-3 fatty acids
compared to the risk experienced by those who did not receive treatment.
When the risk of mortality from heart disease alone was analyzed, the use
of statin drugs and omega-3 fatty acids were found to lower the risk by 22
and 32 percent, respectively. In other word, fish oil was more effective
than than prescription statin drugs (like lipitor) and other drugs that
lower cholesterol in reducing mortality from heart problems, even though
it was not as effective at lowering cholesterol.
Several published trials demonstrate that higher intake levels, blood
levels, and brain levels of EPA and DHA may help preserve cognitive
function as we age and reduce the risk of senile dementia and
Alzheimer's disease.(16) DHA is the most common fatty acid in the brain
and the brains of Alzheimer's patients have been shown to contain a
lower content of DHA.(17) Two recent studies in the American
Journal of Clinical Nutrition indicate that a moderate intake of EPA
and DHA is strongly associated with reduce risk of cognitive
decline.(18,19)
Another recent study also found that young men who have higher levels of
omega 3 fats, esp. DHA, in their blood, have more bone density.(14)
HISTORICAL DISCUSSION
Humans evolved consuming a diet that contained approximately equal amounts
of omega-6 and omega-3 fats. As consumption of omega-3 fats has decreased
and consumption of omega-6 fats has increased, the modern diet in Western cultures
now contains a ratio of omega-6 to omega-3 fats of approximately 20 or
30:1.(1) This is due
to several
factors:
1. Increased intake of vegetable oils from corn, safflower, sunflower,
cottonseed, and soy, which contain primarily omega-6 fats.
2. Decrease in fish consumption compared to primitive
cultures.
3. Cultivated animal meats, vegetables, eggs and even fish that are lower
in omega-3 fatty acids.(2,3,4) Cattle and chickens, for example, are fed
grains that are high in omega-6 fats, thus resulting in cattle and
chickens who have higher levels of omega-6 fats in their meat.
In order to positively influence our health
status and reduce inflammation in our bodies, we should
attempt to increase consumption of omega-3 fatty acids
while reducing consumption of omega-9 and omega-6 fatty
acids. This can be accomplished by reducing the
consumption of meat (which is high in arachidonic acid),
hydrogenated oils (such as found in margarine), and
vegetable oils that contain omega-6, such as corn oil and safflower
oil. We should
make an effort to consume sources of omega-3 fatty acids, such as olive oil and cold water fish, such as
salmon.
Should I take flax seed oil supplements?
What about supplementing with flax seed oil? I used to be a big believer
in flax oil supplements, however, it is now becoming clear from the
literature that fish oil is the preferred form of omega-3 oil
supplement. For one thing, only
a small percentage of the ALA in flax oil is converted by the body into
EPA and DHA, the most active forms of omega-3 in the body.
Secondly, in recent research, there appears
to be an association between elevated levels of ALA in the body and
increased risk of prostate cancer.(11) Therefore, we do not recommend
supplements of flax seed oil. Likewise, mixed oil supplements that
include a combination of omega-3, omega-6, and omega-9 oils should probably be avoided, as we already take in
too much omega-6 fats and this would just continue the imbalance. Eat
wild salmon or other fish at least two times per week and supplement
daily with a high quality fish oil (EPA/DHA) supplying at least 500mg
per day of both EPA and DHA. As always, check with your doctor
to make sure that these recommendations are appropriate for you.
References:
1. Simopoulos AP. Essential fatty acids in health and chronic
disease. Am J Clin Nutr. 1999; 70:560S-569S.
2. Crawford MA. Fats in free-living and domestic animals. Lancet.
1968; 1: 1329-33.
3. Van Vliet T, Katan MB. Lower ratio of omega-3 to omega-6 fats in cultured than in wild
fish. Am J Clin Nutr 1990; 51:1-2.
4. Simopoulos AP, Salem N. Omega-3 fats in eggs from
range-fed Greek chickens. N Engl J of Med. 1986; 315:833
(letter).
5. De Lorgeril M, Renaud S, Mamelle N. Mediterranean
linolenic acid-rich diet in secondary prevention of coronary heart
disease. Lancet. 1994; 343: 1454-9.
6. Burr ML, Fehily AM, Gilbert JF, et al.
Effects of changes in fat, fish and fibre intakes on death and myocardial
infarction: diet and reinfarction trial (DART). Lancet 1989; 2:757-61.
7. Raheja BS, Sadikot SM, Phatak RB, Rao MB. Significance of
the omega-6/omega-3 ratio for insulin action in diabetes. Ann NY. Acad
Sci. 1993; 683: 258-71.
8. Donadio JV Jr, Bergsalh EJ, Offord KP et al. A controlled
trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative
Group. N Engl J Med. 1994; 331: 1194-9.
9. Kremer JM, Lawrence DA, Petrillo GF, et al.
Effects of high-dose fish oil on rheumatoid arthritis
after stopping nonsteroidal antiinflammatory drugs. Arthritis Rheum 1995.
38(8): 1107-14.
10.
11. Leitzmann MF, Stampfer MJ, Michaud DS, et al. Dietary intake of n-3
and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr
2004;80:214-216.
12. GISSI-Prevenzione Investigators.
Dietary supplementation with n-3 polyunsaturated fatty
acids and vitamin E after myocardial infarction: results
of the GISSI-Prevenzione trial. Lancet. 1999;
354(9177): 447-55. (No individual authors were listed.
Nearly 50 scientists were involved, and the trial centers
numbered over 200. The Medline UI: 99392837 can be used
to locate the abstract and order the article.)
13. Studer M, Briel M, Leimenstoll B, et
al. Effect of different antilipidemic agents and diets on mortality:
A systematic review. Arch Intern Med. 2005;165:725-730.
14. Högström
M, Nordström P, Nordström A. N–3 Fatty acids are positively associated
with peak bone mineral density and bone accrual in healthy men: the NO2
Study. Am. J. Clinical Nutrition, Mar 2007; 85: 803 - 807.
15.
16. Conquer JA, Tierney MC, Zecevic J, et al. Fatty acid analysis
of blood plasma of patients with Alzheimer's disease, other types of
dementia, and cognitive impairment. Lipids. 2000; 35:1305-12.
17. Connor WE, Connor SL. The importance of fish and
docasahexanoic acid in Alzheimer's disease. Am J Clin Nutr. 2007;
85:929-30.
18. Beydoun MA, Kaufman JS, Satia JA, et al. Plasma n-3 fatty
acids and the risk of cognitive decline in older adults: the
Atherosclerosis Risk Communities Study. Am J Clin Nutr. 2007; 85:
1103-11.
19. Van Gelder BM, Tijuis M, Kalmijn S, Kromhout D. Fish
consumption, n-3 fatty acids, and subsequent 5-year cognitive decline in
elder men: the Zutphen Elderly Study. Am J Clin Nutr. 2007;
85:1142-7.
The active ingredients in ginkgo are believed to be
flavinoids, referred to as ginkgo flavone glycosides, and
terpenoids (ginkgolides and bilobalide). Most of the
research has used a standardized extract containing 24%
ginkgo flavone glycosides and 6% terpenoids, at a dose of
40 to 80 mg three times per day.(7)
Ginkgo has been shown to improve blood flow to the brain
through several mechanisms, including improving
vasoregulatory activity, decreasing blood viscosity, and
antagonizing platelet activating factor.(8)
Ginkgo is an anti-oxidant that acts to scavenge free
radicals and to prevent peroxidation of lipids.
Alzheimer's disease results from free radical damage to
the brain, esp. peroxidation of the lipids that make up
the membranes of the neurons in the brain. Thus, ginkgo
may help to reduce loss of cognitive function in patients
with Alzheimer's and other forms of dementia.(5)
Ginkgo must be considered relatively safe, given the studies that have been conducted over the last 15 years. There have only been a few, relatively minor reported side effects related to taking ginkgo, including headaches and dizziness. Large dosages have occasionally caused mild stomach or intestinal upset. Ginkgo may be contra-indicated for patients taking blood thinners such as coumadin or warfarin.
References:
1. Le Bars PL, Kieser M, Itil KZ. A 26-week analysis of a
double-blind, placebo-controlled trial of the ginkgo biloba extract EGb
761 in dementia. Dement Geriatr Cogn Disord. 2000
Jul-Aug;11(4):230-7.
2. Ernst E, Stevinson C. Ginkgo biloba for
tinnitus: a review. Clin Otolaryngol. 1999 Jun;24(3):164-7.
3. Schubert H, Halama P. Dpressive episode primarily unresponsive to
therapy in elderly patients. Efficacy of Gingko Biloba in combination with
antidepressants. Geriatr Forsch. 1993; 3: 45-53.
4. Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of
intermittent claudication: a meta-analysis of randomized trials. Am J
Med. 2000 Mar;108(4):276-81.
5. Kleijenen J, Knipschild P. Ginkgo
biloba for cerebral insufficiency. Br J Clin Pharmac.
1992; 34:352-8.
6. Le Bars PL, Katz MM, Berman N, et al. A placebo
controlled, double-blind, randomized trial of an extract
of Ginkgo biloba for dementia. JAMA. 1997;
278:1327-32.
7. Kleijenen J, Knipschild P. Ginkgo biloba. Lancet
1992; 340:1136-9.
8. Krigelstein J, Beck T, Seibert A. Influence of an
extract of Gingko biloba on cerebral blood flow
and metabolism. Life Sci. 1986; 39:2327-34.
NOT RECOMMENDED:
The following are some supplements that we do not recommend as there is either a lack of sufficient research at the present time to back up the claims made about them or there is considerable concern about their safety: